Sign in
BLFS Stock Price, Chart, Stats & News
BioLife Solutions, Inc.
Save
BioLife Solutions, Inc. (BLFS) does not currently pay a dividend.
1.88B
Market cap
37.37x
Current P/E
238.10x
Forward P/E
BLFS chart
Fundamentals
Gross margin | 64.56% |
Operating margin | -12.61% |
Pretax margin | -12.56% |
Net margin | -12.61% |
Effective tax rate | -0.41% |
ROA | -2.99% |
ROE | -3.40% |
D/E | 0.05x |
Interest coverage ratio | -18.38x |
BLFS valuation
P/E | 37.37x |
P/S | 9.33x |
P/B | 2.39x |
P/CF | 44.13x |
P/FCF | 70.14x |
P/OCF | 44.13x |
PEG | 0.21x |
EV multiple | -113.85x |
About
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing.
Similar securities
Based on sector and market capitalization
Report issue